Analysts are intrested in these 5 stocks: ( (TTD) ), ( (HUBS) ), ( (DELL) ), ( (CMXHF) ) and ( (OKLO) ). Here is a breakdown of their recent ratings and the rationale behind them.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The Trade Desk is suddenly facing colder winds from Wall Street. Analyst Ralph Schackart cut TTD to Hold after years of strong performance, warning that growth has slowed and competition is biting into market share. Revenue has become more volatile, Kokai’s higher pricing is upsetting advertisers, and a major agency has reportedly stopped recommending the platform, even though margins and international growth remain solid.
HubSpot, once a high‑flyer of cloud marketing tools, is now in the “prove it” camp for analysts. Arjun Bhatia and Steven Koenig both downgraded HUBS to Hold/Neutral, pointing to slower net new ARR, a sluggish start to Q2, and AI‑related disruptions to sales cycles. Revenue is still growing around the high‑teens and pricing changes give a temporary boost, but investors are being told to wait for clear, sustainable reacceleration before expecting the stock to break out.
Dell Technologies is a victim of its own success in the eyes of the market. David Vogt downgraded DELL to Neutral, arguing that the surge in AI‑server demand is largely priced in after a roughly 170% share rally in 12 months. Dell’s AI‑optimized servers, supply‑chain strength and potential share gains from rivals could still lift earnings, yet today’s valuation already assumes very strong EPS growth, leaving a more balanced risk‑reward for new buyers.
Australian biotech giant CSL also moves to the sidelines as doubts about its recovery deepen. Laura Sutcliffe cut CMXHF to Neutral, saying investors may be underestimating how long a turnaround in immunoglobulin, albumin and the Behring business will take. At about 11 times FY27 core EPS the stock looks cheap on paper, but weakening growth assumptions, lost U.S. Ig share, tougher competition from Grifols and a lack of a clear recovery timeline justify caution.
Oklo Inc. is drawing attention as a bold bet on advanced nuclear power, but analysts are not ready to go all‑in. Jeremy Tonet initiated coverage of OKLO at Hold with an $83 target, highlighting its 15.2 GW pipeline, DOE backing and integrated model spanning power, fuel and isotopes. The opportunity around AI data centers and industrial users is huge, yet the business still relies on a handful of binding contracts and must prove it can execute first‑of‑a‑kind projects before sentiment can truly turn bullish.